
Vertex Pharmaceuticals Incorporated
VRTXHealthcare|Biotechnology|US
$547.09
+4.59 (+0.85%)
DCF Value
$349.13
Tangible Book / Share
$39.31
Graham Number
$170.60
Cash / Share
$24.87
Ownership Breakdown
99.8%
Float
253.5M
Shares Outstanding
252.9M
Float Shares
Major Holders (5)
Combined: 33.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Capital World Investors | Investment adviser | 10.10% | 25,695,015 | May 14, 2026 | 13D/G |
| Capital Research Global Investors | Investment adviser | 8.30% | 21,139,169 | May 14, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 7.49% | 19,036,076 | Apr 30, 2026 | 13D/G |
| FMR LLC | Holding company | 3.60% | 9,220,826 | Feb 12, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 3.60% | 9,220,826 | Feb 12, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 314,323.622 acquired · 356,279 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Brennan Daniel J. | director | Oct 20, 2026 | AWARD | 795 | $503.47 | $400.3K | Form 4 |
| Brennan Daniel J. | director: | Oct 20, 2026 | OTHER | 0 | — | — | Form 4 |
| SACHS BRUCE I | director | Oct 15, 2026 | AWARD | 92.694 | — | — | Form 4 |
| Garber Alan M | director | Oct 15, 2026 | AWARD | 29.272 | — | — | Form 4 |
| van Grunsven Jasper | EVP, CP and NPPO | Sep 8, 2026 | AWARD | 8,682 | — | — | Form 4 |
| van Grunsven Jasper | officer | Sep 8, 2026 | OTHER | 0 | — | — | Form 4 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Aug 28, 2026 | AWARD | 5,000 | — | — | Form 4 |
| SACHS BRUCE I | director | Aug 27, 2026 | GIFT | 6,000 | — | — | Form 4 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Jul 21, 2026 | AWARD | 8,251 | — | — | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Jul 21, 2026 | AWARD | 8,251 | — | — | Form 4 |
| SACHS BRUCE I | director | Jul 15, 2026 | AWARD | 99.941 | — | — | Form 4 |
| Garber Alan M | director | Jul 15, 2026 | AWARD | 31.56 | — | — | Form 4 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Jul 2, 2026 | SELL | 1,500 | $524.99 | $787.5K | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Jul 2, 2026 | SELL | 1,541 | $519.00 | $799.8K | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Jul 1, 2026 | SELL | 828 | $502.71 | $416.2K | Form 4 |
| Bozic Carmen | EVP and CMO | Jun 26, 2026 | SELL | 596 | $482.50 | $287.6K | Form 4 |
| Bozic Carmen | EVP and CMO | Jun 18, 2026 | SELL | 1,020 | $462.17 | $471.4K | Form 4 |
| Bozic Carmen | EVP and CMO | Jun 15, 2026 | SELL | 4,062 | $450.00 | $1.8M | Form 4 |
| Bozic Carmen | EVP and CMO | Jun 5, 2026 | SELL | 1,745 | $450.00 | $785.3K | Form 4 |
| Bozic Carmen | EVP and CMO | May 29, 2026 | SELL | 1,974 | $450.00 | $888.3K | Form 4 |
| Bunnage Mark E. | EVP, Chief Scientific Officer | May 15, 2026 | SELL | 33 | $453.45 | $15.0K | Form 4 |
| Bozic Carmen | EVP and CMO | May 15, 2026 | SELL | 1,354 | $453.45 | $614.0K | Form 4 |
| Bozic Carmen | EVP and CMO | May 12, 2026 | SELL | 6,988 | $450.00 | $3.1M | Form 4 |
| Upadhyay Suketu | director | May 1, 2026 | AWARD | 796 | — | — | Form 4 |
| Upadhyay Suketu | director | May 1, 2026 | AWARD | 2,866 | $424.45 | $1.2M | Form 4 |
| Upadhyay Suketu | director | May 1, 2026 | DISPOSED | 796 | — | — | Form 4 |
| Thornberry Nancy | director | May 1, 2026 | AWARD | 472 | — | — | Form 4 |
| Thornberry Nancy | director | May 1, 2026 | DISPOSED | 398 | — | — | Form 4 |
| Thornberry Nancy | director | May 1, 2026 | AWARD | 1,433 | $424.45 | $608.2K | Form 4 |
| Thornberry Nancy | director | May 1, 2026 | AWARD | 398 | — | — | Form 4 |
| Schneider Jennifer | director | May 1, 2026 | AWARD | 472 | — | — | Form 4 |
| Schneider Jennifer | director | May 1, 2026 | AWARD | 1,433 | $424.45 | $608.2K | Form 4 |
| Schneider Jennifer | director | May 1, 2026 | DISPOSED | 796 | — | — | Form 4 |
| Schneider Jennifer | director | May 1, 2026 | AWARD | 796 | — | — | Form 4 |
| SACHS BRUCE I | director | May 1, 2026 | AWARD | 2,866 | $424.45 | $1.2M | Form 4 |
| MCKENZIE DIANA | director | May 1, 2026 | AWARD | 796 | — | — | Form 4 |
| MCKENZIE DIANA | director | May 1, 2026 | AWARD | 943 | — | — | Form 4 |
| MCKENZIE DIANA | director | May 1, 2026 | DISPOSED | 796 | — | — | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | May 1, 2026 | SELL | 1,104 | $425.02 | $469.2K | Form 4 |
| Lagarde Michel | director | May 1, 2026 | AWARD | 2,866 | $424.45 | $1.2M | Form 4 |
| Garber Alan M | director | May 1, 2026 | AWARD | 472 | — | — | Form 4 |
| Garber Alan M | director | May 1, 2026 | AWARD | 1,433 | $424.45 | $608.2K | Form 4 |
| CARNEY LLOYD | director | May 1, 2026 | AWARD | 2,866 | $424.45 | $1.2M | Form 4 |
| Bhatia Sangeeta N. | director | May 1, 2026 | AWARD | 943 | — | — | Form 4 |
| Bhatia Sangeeta N. | director | May 4, 2026 | SELL | 318 | $423.73 | $134.7K | Form 4 |
| Upadhyay Suketu | director | Apr 15, 2026 | AWARD | 80.508 | — | — | Form 4 |
| SACHS BRUCE I | director | Apr 15, 2026 | AWARD | 107.345 | — | — | Form 4 |
| Garber Alan M | director | Apr 15, 2026 | AWARD | 33.898 | — | — | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Apr 1, 2026 | SELL | 978 | $449.17 | $439.3K | Form 4 |
| Bozic Carmen | EVP and CMO | Mar 27, 2026 | SELL | 2,329 | $450.95 | $1.1M | Form 4 |
| Bozic Carmen | EVP and CMO | Mar 13, 2026 | SELL | 2,329 | $481.79 | $1.1M | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Mar 11, 2026 | SELL | 2,633 | $498.42 | $1.3M | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Mar 4, 2026 | SELL | 2,437 | $475.30 | $1.2M | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Mar 2, 2026 | SELL | 892 | $495.96 | $442.4K | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Mar 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Mar 1, 2026 | OTHER | 7,044 | $155.57 | $1.1M | Form 4 |
| Liu Joy | EVP and Chief Legal Officer | Mar 1, 2026 | OTHER | 5,363 | $187.53 | $1.0M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 400 | $479.75 | $191.9K | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 120 | $481.50 | $57.8K | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 240 | $482.84 | $115.9K | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 2,510 | $487.13 | $1.2M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 3,278 | $488.27 | $1.6M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 460 | $489.32 | $225.1K | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 2,725 | $490.54 | $1.3M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 949 | $491.30 | $466.2K | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 2,520 | $493.29 | $1.2M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 3,498 | $494.33 | $1.7M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 15,580 | $495.38 | $7.7M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 5,995 | $496.16 | $3.0M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 27, 2026 | SELL | 1,725 | $496.95 | $857.2K | Form 4 |
| Bozic Carmen | EVP and CMO | Feb 27, 2026 | SELL | 2,329 | $480.31 | $1.1M | Form 4 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Feb 26, 2026 | SELL | 357 | $483.36 | $172.6K | Form 4 |
| WAGNER CHARLES F JR | EVP, CO & FO | Feb 24, 2026 | TAX W/H | 1,744 | $485.11 | $846.0K | Form 4 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 24, 2026 | TAX W/H | 1,627 | $485.11 | $789.3K | Form 4 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 25, 2026 | SELL | 260 | $486.35 | $126.5K | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 24, 2026 | TAX W/H | 1,518 | $485.11 | $736.4K | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 25, 2026 | SELL | 1,846 | $486.35 | $897.8K | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Feb 24, 2026 | TAX W/H | 873 | $485.11 | $423.5K | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Feb 25, 2026 | SELL | 2,500 | $486.35 | $1.2M | Form 4 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Feb 25, 2026 | SELL | 2,410 | $489.00 | $1.2M | Form 4 |
| LEIDEN JEFFREY M | director, officer: Executive Chairman | Feb 24, 2026 | TAX W/H | 3,547 | $485.11 | $1.7M | Form 4 |
| Kewalramani Reshma | director, officer: CEO & President | Feb 24, 2026 | TAX W/H | 4,981 | $485.11 | $2.4M | Form 4 |
| Bunnage Mark E. | EVP, Chief Scientific Officer | Feb 24, 2026 | TAX W/H | 582 | $485.11 | $282.3K | Form 4 |
| Bunnage Mark E. | EVP, Chief Scientific Officer | Feb 25, 2026 | SELL | 620 | $486.35 | $301.5K | Form 4 |
| Bozic Carmen | EVP and CMO | Feb 24, 2026 | TAX W/H | 1,453 | $485.11 | $704.9K | Form 4 |
| Biller Jonathan | EVP and Chief Legal Officer | Feb 24, 2026 | TAX W/H | 1,144 | $485.11 | $555.0K | Form 4 |
| Biller Jonathan | EVP and Chief Legal Officer | Feb 25, 2026 | SELL | 945 | $486.35 | $459.6K | Form 4 |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 24, 2026 | TAX W/H | 1,627 | $485.11 | $789.3K | Form 4 |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 25, 2026 | SELL | 668 | $486.35 | $324.9K | Form 4 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Feb 24, 2026 | TAX W/H | 546 | $485.11 | $264.9K | Form 4 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Feb 25, 2026 | SELL | 223 | $486.35 | $108.5K | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | OPTION EX. | 25,026 | $187.53 | $4.7M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 920 | $463.91 | $426.8K | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 2,730 | $465.05 | $1.3M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 1,848 | $465.80 | $860.8K | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 10,263 | $467.75 | $4.8M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | OPTION EX. | 23,479 | $155.57 | $3.7M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 19,662 | $468.57 | $9.2M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 7,241 | $469.61 | $3.4M | Form 4 |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 19, 2026 | SELL | 11,712 | $470.54 | $5.5M | Form 4 |
Congress & Senate Trades (59)
Ro KhannaHouse · CA17Sep 4, 2026
David TaylorHouse · OH02Aug 26, 2026
Ro KhannaHouse · CA17Apr 13, 2026
Alan ArmstrongSenateMar 27, 2026
David TaylorHouse · OH02Jan 29, 2026
Ro KhannaHouse · CA17Sep 29, 2025
Ro KhannaHouse · CA17Sep 5, 2025
Ro KhannaHouse · CA17Aug 26, 2025
Ro KhannaHouse · CA17Aug 26, 2025
David TaylorHouse · OH02Aug 7, 2025
Ro KhannaHouse · CA17Aug 4, 2025
Lisa C. McClainHouse · MI09Jun 11, 2025
Lisa C. McClainHouse · MI09Jun 10, 2025
Jefferson ShreveHouse · IN06May 12, 2025
Byron DonaldsHouse · FL19Mar 20, 2025
Byron DonaldsHouse · FL19Mar 20, 2025
Jefferson ShreveHouse · IN06Mar 13, 2025
Jefferson ShreveHouse · IN06Feb 24, 2025
Lisa C. McClainHouse · MI09Dec 11, 2024
Ro KhannaHouse · CA17Nov 15, 2024
Julia LetlowHouse · LA05Oct 23, 2024
Ro KhannaHouse · CA17Sep 9, 2024
Thomas Hawley TubervilleSenate · ALMay 3, 2024
Greg StantonHouse · AZ04Oct 24, 2023
Ro KhannaHouse · CA17Oct 2, 2023
Greg StantonHouse · AZ04Sep 26, 2023
Ro KhannaHouse · CA17Jun 29, 2023
Ro KhannaHouse · CA17May 23, 2023
Ro KhannaHouse · CA17Mar 24, 2023
Ro KhannaHouse · CA17Mar 14, 2023
Ro KhannaHouse · CA17Feb 10, 2023
Ro KhannaHouse · CA17Jan 11, 2023
Ro KhannaHouse · CA17Jan 9, 2023
Ro KhannaHouse · CA17Dec 6, 2022
Ro KhannaHouse · CA17Dec 6, 2022
Ro KhannaHouse · CA17Dec 5, 2022
Ro KhannaHouse · CA17Oct 20, 2022
Thomas Hawley TubervilleSenate · ALOct 6, 2022
Ro KhannaHouse · CA17Sep 16, 2022
Ro KhannaHouse · CA17Jul 18, 2022
Ro KhannaHouse · CA17Jun 30, 2022
Ro KhannaHouse · CA17Jun 24, 2022
William R. KeatingHouse · MA09Mar 29, 2022
Peter MeijerHouse · MI03Jan 28, 2021
Kenny MarchantHouse · TX24Nov 19, 2020
Josh GottheimerHouse · NJ05Sep 19, 2019
Donna ShalalaHouse · FL27Jun 24, 2019
Donna ShalalaHouse · FL27Apr 18, 2019
Josh GottheimerHouse · NJ05Apr 11, 2019
Gilbert CisnerosHouse · CA39Feb 27, 2019